Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease—Perspective from the Veterans Affair Healthcare System-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease—Perspective from the Veterans Affair Healthcare System

Published:2021-02-01 Issue: Volume: Page:
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Jia Xiaoming^ORCID,Lee Michelle T.,Ramsey David J.,Al Rifai Mahmoud,Mahtta Dhruv,Krittanawong Chayakrit,Akeroyd Julia M.,Matheny Michael E.,Gobbel Glenn,Stone Neil J.,Ballantyne Christie M.,Petersen Laura A.,Virani Salim S.

Funder

Department of Veterans Affairs Health Services Research & Development Service Investigator Initiated Grant

American Heart Association

American Diabetes Association Clinical Science and Epidemiology award

Houston VA Health Services Research & Development Center for Innovations grant

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10557-021-07148-4.pdf

Reference23 articles.

1. Cholesterol Treatment Trialists C, Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015;385(9976):1397–405.

2. Virani SS, Woodard LD, Chitwood SS, Landrum CR, Urech TH, Wang D, et al. Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease. Am Heart J. 2011;162(4):725–32. e1.

3. Rodriguez F, Lin S, Maron DJ, Knowles JW, Virani SS, Heidenreich PA. Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: practice impact of the new cholesterol guidelines. Am Heart J. 2016;182:97–102.

4. Pokharel Y, Tang F, Jones PG, Nambi V, Bittner VA, Hira RS, et al. Adoption of the 2013 American College of Cardiology/American Heart Association cholesterol management guideline in cardiology practices Nationwide. JAMA Cardiol. 2017;2(4):361–9.

5. Mahtta D, Ahmed ST, Ramsey DJ, Akeroyd JM, Lee MT, Rodriguez F, et al. Statin prescription rates, adherence, and associated clinical outcomes among women with PAD and ICVD. Cardiovasc Drugs Ther. 2020;34(6):745–54.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibodies, Gene Silencing and Gene Editing (CRISPR) Therapies for the Treatment of Hyperlipidemia—The Future Is Here;Pharmaceutics;2023-01-30

2. Reviews on Statin-associated Side Effects;Statins - From Lipid-Lowering Benefits to Pleiotropic Effects;2023-01-19

3. Highlights of Cardiovascular Disease Studies Presented at the 2021 American Heart Association Scientific Sessions;Current Atherosclerosis Reports;2022-01

4. Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system;Journal of Clinical Lipidology;2021-11

5. Epidemiology and risk factors for stroke in young individuals: implications for prevention;Current Opinion in Cardiology;2021-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3